跳至主要内容
临床试验/JPRN-UMIN000024552
JPRN-UMIN000024552已完成4 期

Investigation of satisfaction, efficacy and safety after switching from daily GLP-1 receptor agonist to weekly dulaglutide in patients with type 2 diabetes -open label, randomized, parallel group controlled clinical study- - Study for satisfaction and efficacy of dulaglutide

Hokkaido University Graduate School0 个研究点目标入组 32 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who were taking weekly GLP-1 receptor agonist at the time of obtaining informed consent 2)Patients who have experienced severe diabetic ketosis, diabetic coma, or past history of pre-coma within six months 3)Patients with pregnancy or lactation 4)Patients who are taking systemic corticosteroid 5)Type 1 diabetes 6)Patients with severe infection, pre or post operation and severe trauma 7)Patients with severe liver dysfunction 8)Patients with severe renal dysfunction 9)Patients who are deemed to be unsuitable by the investigator

研究者

相似试验

Investigation of satisfaction, efficacy and safety... | 临床试验